Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.05
HRT's Cash to Debt is ranked lower than
96% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. HRT: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
HRT' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 3.37 Max: No Debt
Current: 0.05
Equity to Asset 0.47
HRT's Equity to Asset is ranked lower than
72% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. HRT: 0.47 )
Ranked among companies with meaningful Equity to Asset only.
HRT' s Equity to Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.86 Max: 0.96
Current: 0.47
0.39
0.96
F-Score: 4
Z-Score: 2.44
M-Score: -2.91
WACC vs ROIC
3.96%
-5.85%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -3.12
HRT's Operating margin (%) is ranked lower than
57% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 2.61 vs. HRT: -3.12 )
Ranked among companies with meaningful Operating margin (%) only.
HRT' s Operating margin (%) Range Over the Past 10 Years
Min: -15.6  Med: 2.55 Max: 16.65
Current: -3.12
-15.6
16.65
Net-margin (%) -4.47
HRT's Net-margin (%) is ranked lower than
58% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. HRT: -4.47 )
Ranked among companies with meaningful Net-margin (%) only.
HRT' s Net-margin (%) Range Over the Past 10 Years
Min: -29.73  Med: 1.69 Max: 11.2
Current: -4.47
-29.73
11.2
ROE (%) -13.00
HRT's ROE (%) is ranked lower than
62% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 0.98 vs. HRT: -13.00 )
Ranked among companies with meaningful ROE (%) only.
HRT' s ROE (%) Range Over the Past 10 Years
Min: -48.14  Med: 2.28 Max: 16.37
Current: -13
-48.14
16.37
ROA (%) -6.27
HRT's ROA (%) is ranked lower than
56% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. HRT: -6.27 )
Ranked among companies with meaningful ROA (%) only.
HRT' s ROA (%) Range Over the Past 10 Years
Min: -33.69  Med: 2.00 Max: 14.81
Current: -6.27
-33.69
14.81
ROC (Joel Greenblatt) (%) -6.22
HRT's ROC (Joel Greenblatt) (%) is ranked lower than
55% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 4.07 vs. HRT: -6.22 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HRT' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -31.98  Med: 4.80 Max: 34.52
Current: -6.22
-31.98
34.52
Revenue Growth (3Y)(%) 1.20
HRT's Revenue Growth (3Y)(%) is ranked lower than
61% of the 234 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. HRT: 1.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HRT' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -23.1  Med: 1.60 Max: 34.6
Current: 1.2
-23.1
34.6
EPS Growth (3Y)(%) -31.20
HRT's EPS Growth (3Y)(%) is ranked lower than
88% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. HRT: -31.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HRT' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.1  Med: 5.40 Max: 162.1
Current: -31.2
-44.1
162.1
» HRT's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-13)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

HRT Guru Trades in Q2 2015

Jim Simons 89,500 sh (+2.17%)
» More
Q3 2015

HRT Guru Trades in Q3 2015

Jim Simons 90,400 sh (+1.01%)
» More
Q4 2015

HRT Guru Trades in Q4 2015

Jim Simons 91,000 sh (+0.66%)
» More
Q1 2016

HRT Guru Trades in Q1 2016

Jim Simons 92,500 sh (+1.65%)
» More
» Details

Insider Trades

Latest Guru Trades with HRT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:DTXMF, OTCPK:BLOZF, OTCPK:NIMU, OTCBB:NAOV, NAS:VSCP, OTCPK:NUMD, OTCPK:PBIO, OTCPK:LCTC, OTCPK:ABMT, OTCPK:GIDYL, NAS:DHRM, NAS:SSH, NAS:MDVX, NAS:KOOL, NAS:MDGS, OTCPK:ACAR, NAS:SMLR, OTCPK:ZYXI, NAS:DYNT, NAS:AMDA » details
Arrhythmia Research Technology is a contract manufacturing organization. It produces medical device technologies requiring precision machining and injection molding.

Arrhythmia Research Technology was incorporated under the laws of the State of Louisiana in 1981 and reincorporated under the laws of the State of Delaware in 1987. It completed an initial public offering in 1988. The Company through its wholly-owned subsidiary is a manufacturer specializing in plastic molding, precision metal and plastics machining and precious metal coating. It is also engaged in the development and licensing of signal averaged electrocardiography (SAECG) software, through its Predictor brand. The Company's technologies used in analyzing high resolution heart signals. Its Predictor software is used in research and clinical environments to diagnose the risk of certain heart arrhythmias. The Company invests in research and development, product support and sales efforts. The Company sells its services to its customers to provide product life cycle support to their product manufacturing needs. It provides complex value added US based manufacturing capabilities in injection molding, machining and plating/coating, mold making, maintenance and repair. The Company's operations are subject to government regulations which establish compliance standards and result in costs to comply in order to participate in certain markets.

Ratios

vs
industry
vs
history
P/B 1.93
HRT's P/B is ranked higher than
65% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. HRT: 1.93 )
Ranked among companies with meaningful P/B only.
HRT' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 1.17 Max: 6.37
Current: 1.93
0.26
6.37
P/S 0.62
HRT's P/S is ranked higher than
88% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.99 vs. HRT: 0.62 )
Ranked among companies with meaningful P/S only.
HRT' s P/S Range Over the Past 10 Years
Min: 0.2  Med: 0.66 Max: 4.75
Current: 0.62
0.2
4.75
POCF 10.98
HRT's POCF is ranked higher than
75% of the 130 Companies
in the Global Medical Devices industry.

( Industry Median: 19.79 vs. HRT: 10.98 )
Ranked among companies with meaningful POCF only.
HRT' s POCF Range Over the Past 10 Years
Min: 1.78  Med: 11.33 Max: 43.28
Current: 10.98
1.78
43.28
EV-to-EBITDA 20.83
HRT's EV-to-EBITDA is ranked lower than
63% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 17.82 vs. HRT: 20.83 )
Ranked among companies with meaningful EV-to-EBITDA only.
HRT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -17  Med: 6.70 Max: 33.3
Current: 20.83
-17
33.3
Current Ratio 1.66
HRT's Current Ratio is ranked lower than
75% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.88 vs. HRT: 1.66 )
Ranked among companies with meaningful Current Ratio only.
HRT' s Current Ratio Range Over the Past 10 Years
Min: 1.04  Med: 3.77 Max: 10.41
Current: 1.66
1.04
10.41
Quick Ratio 1.11
HRT's Quick Ratio is ranked lower than
77% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. HRT: 1.11 )
Ranked among companies with meaningful Quick Ratio only.
HRT' s Quick Ratio Range Over the Past 10 Years
Min: 0.63  Med: 2.58 Max: 8.09
Current: 1.11
0.63
8.09
Days Inventory 48.65
HRT's Days Inventory is ranked higher than
88% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 136.99 vs. HRT: 48.65 )
Ranked among companies with meaningful Days Inventory only.
HRT' s Days Inventory Range Over the Past 10 Years
Min: 45.54  Med: 58.80 Max: 72.83
Current: 48.65
45.54
72.83
Days Sales Outstanding 59.12
HRT's Days Sales Outstanding is ranked higher than
65% of the 271 Companies
in the Global Medical Devices industry.

( Industry Median: 68.67 vs. HRT: 59.12 )
Ranked among companies with meaningful Days Sales Outstanding only.
HRT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.92  Med: 53.82 Max: 65.94
Current: 59.12
43.92
65.94
Days Payable 34.74
HRT's Days Payable is ranked lower than
76% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 61.70 vs. HRT: 34.74 )
Ranked among companies with meaningful Days Payable only.
HRT' s Days Payable Range Over the Past 10 Years
Min: 15.71  Med: 35.58 Max: 49.86
Current: 34.74
15.71
49.86

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 1.89
HRT's Price/Tangible Book is ranked higher than
76% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 3.76 vs. HRT: 1.89 )
Ranked among companies with meaningful Price/Tangible Book only.
HRT' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.38  Med: 1.20 Max: 10.87
Current: 1.89
0.38
10.87
Price/Median PS Value 0.91
HRT's Price/Median PS Value is ranked higher than
59% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. HRT: 0.91 )
Ranked among companies with meaningful Price/Median PS Value only.
HRT' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.36  Med: 1.08 Max: 16.2
Current: 0.91
0.36
16.2
Earnings Yield (Greenblatt) (%) -4.02
HRT's Earnings Yield (Greenblatt) (%) is ranked lower than
62% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. HRT: -4.02 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HRT' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -4.09  Med: 5.65 Max: 25.9
Current: -4.02
-4.09
25.9
Forward Rate of Return (Yacktman) (%) -14.47
HRT's Forward Rate of Return (Yacktman) (%) is ranked lower than
89% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 7.22 vs. HRT: -14.47 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HRT' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -21  Med: -8.30 Max: 38.8
Current: -14.47
-21
38.8

More Statistics

Revenue (TTM) (Mil) $20.62
EPS (TTM) $ -0.34
Beta0.20
Short Percentage of Float0.85%
52-Week Range $3.52 - 6.47
Shares Outstanding (Mil)2.82
» More Articles for HRT

Headlines

Articles On GuruFocus.com
Longleaf Partners Believe HRT Could Be Their Most Exciting Investment Ever Jun 08 2011 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Nov 10 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Aug 16 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) May 04 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Oct 30 2009 
Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Sep 17 2009 
Weekly CFO Buys Highlight: Arrhythmia Research Technology, Ultra Clean Holdings, Pixelworks, Hospira Aug 16 2009 
Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Aug 12 2009 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Aug 04 2009 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) May 11 2009 

More From Other Websites
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of... Jun 01 2016
Arrhythmia Research Technology, Inc. Announces Results of Annual Meeting of Stockholders Jun 01 2016
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial... May 25 2016
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials May 19 2016
Arrhythmia Research Technology, Inc. :HRT-US: Earnings Analysis: Q1, 2016 By the Numbers May 18 2016
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... May 12 2016
Arrhythmia Research Technology, Inc. Reports 2016 First Quarter Results May 12 2016
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal... Apr 07 2016
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Mar 10 2016
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal... Feb 05 2016
Arrhythmia Research Technology, Inc. Earnings Q3, 2015 Dec 03 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Nov 12 2015
Less-lethal weapons get new interest amid police shootings Aug 25 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Aug 13 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal... Jul 23 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of... Jul 07 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive... Jun 23 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Other Events Jun 16 2015
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure, Financial... Jun 12 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)